MRNA (NASDAQ) Form 144 shows 25,770-share option exercise, prior 36,759 sale
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported a Form 144 notice indicating securities were sold or to be sold under Rule 144 related to a stock option exercise on 06/18/2026. The filing lists 25,770 shares tied to the June 18, 2026 exercise and a separate sale of 36,759 shares on 05/08/2026, with dollar amounts shown in the filing. The transaction method for the exercise is listed as cash and the broker-dealer noted is Fidelity Brokerage Services LLC.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice for exercised/options-related sales filed, procedural disclosure only.
The filing lists a stock option exercise with 25,770 shares on 06/18/2026 and a prior sale of 36,759 shares on 05/08/2026. It names Fidelity Brokerage Services LLC as the broker-dealer and records cash as the settlement method.
These notices are routine compliance disclosures under Rule 144. The timing, beneficial ownership status, and any holding-period or volume-limit qualifiers are not shown in the excerpt; future filings or full Form 144 text would clarify whether sales were permitted under Rule 144 conditions.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
Broker‑dealer financial
FAQ
What does MRNA's Form 144 filing mean?
Who acted as broker-dealer on the reported transactions?
Was cash used to settle the stock option exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.